Min Liu

Min Liu


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2020 in Thoracic Cancer
Verified
Journal Article
Open access
PDF file
LZLei Zhang
Lei Zhang
QZQiliang Zhao
Qiliang Zhao
FYFan Yuan
Fan Yuan
MLMin Liu
Min Liu
Background: Connective tissue disease increases the risk of lung cancer, but whether rheumatoid arthritis (RA) has an effect on the overall survival (OS) rate in this population has not been well studied.Methods: Patients diagnosed with lung cancer between January 2015 and December 2017 were enrolled in this retrospective analysis. Propensity score matching was performed to balance the baseline of the two groups, whereas the differences between patients with and without RA were compared using survival analysis. Further, the effects of interstitial lung disease (ILD) and qi deficiency on survival in cases of RA with lung cancer were examined. Cox regression analysis was applied to predict the factors that influenced the survival of lung cancer to one year.Results: Overall, 154 lung cancer patients, including 136 (88.3%) without RA and 18 (11.7%) with RA, were included. Two comparison cohorts were matched by 1:2 propensity score matching, which yielded 18 lung cancer patients with RA and 36 lung cancer patients without RA. Ultimately, the survival prognosis of lung cancer and RA was worse than that without RA, that of patients with ILD with RA and lung cancer was worse than that among those without RA, and that of patients with qi deficiency with RA and lung cancer was worse than that among those without RA.Conclusions: The survival prognosis of lung cancer patients with RA is worse than that of those without RA. ILD and qi deficiency promote reduced survival when found in conjunction with RA in patients with lung cancer.

17 October 2025 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
XGXiaojing Guo
Xiaojing Guo
SWSiwei Wang
Siwei Wang
JDJiuli Ding
Jiuli Ding
WLWeiwei Liu
Weiwei Liu
JXJiaqi Xu
Jiaqi Xu
MLMin Liu
Min Liu
Periodontitis (PD) is a chronic inflammatory disease linked to microbial dysbiosis, while rheumatoid arthritis (RA) is an autoimmune disorder characterized by anti-citrullinated protein antibodies (ACPA). Despite their distinct etiologies, a clinical and serological association between PD and RA has been observed. Oral microorganisms, especially Porphyromonas gingivalis (P. gingivalis), may contribute to RA onset or progression through dissemination to joints or systemic inflammation. This review explores a: the role of oral microbiota and immune responses in RA b; clinical pathogenic pathways from oral pathogens to the joints c; mechanistic studies on the impact of periodontal pathogens on RA; and d. preventive and therapeutic strategies. P. gingivalis and other periodontal pathogens have been detected in synovial tissues and fluids of RA patients. Microbiome analyses show a more diverse oral microbiota with elevated periodontal disease-associated bacteria in RA patients. Studies demonstrate that P. gingivalis can induce citrullination, autoantibody production, and inflammation, exacerbating joint damage. Future research should investigate the impact of periodontal therapy and RA treatments on the oral microbiota, while large-scale clinical trials are needed to validate the causal relationship between periodontal pathogens and RA.

1 April 2025 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
JXJiaqi Xu
Jiaqi Xu
CJConghan Jiao
Conghan Jiao
HDHaiwei Du
Haiwei Du
XGXiaojing Guo
Xiaojing Guo
MWMutian Wang
Mutian Wang
RSRongjiang Shao
Rongjiang Shao
Objective: This study investigates the therapeutic mechanisms of Xijiao Dihuang Decoction (XJDHD) in sepsis-induced acute lung injury (SALI) through an integrated approach, including network pharmacology, molecular docking, molecular dynamics simulations, and in vitro experiments. Methods: Network pharmacology identified active ingredients and targets in Xijiao Dihuang Decoction. Molecular docking and dynamics simulations evaluated binding affinity and stability with key targets. In vitro experiments on LPS-stimulated A549 cells substantiated Xijiao Dihuang Decoction’s anti-inflammatory, antioxidant, and anti-apoptotic effects. Results: Network pharmacology identified 20 active components among 182 Sepsis-Induced Acute Lung Injury targets. Molecular docking revealed strong binding affinity (binding energies ≤ − 5.0 kcal/mol) for β-sitosterol with AKT1 and TNF. Molecular dynamics confirmed the complex stability. In vitro experiments demonstrated that Xijiao Dihuang Decoction significantly reduced inflammatory cytokines IL-6, TNF-α, and IL-1β (p< 0.001), increased SOD and CAT mRNA (p< 0.05), downregulated MyD88 mRNA (p< 0.05), and modulated apoptosis-related proteins (Bax, Bcl-2, Cleaved-Caspase-3; p< 0.05). The modulation of the PI3K/Akt pathway was confirmed by p-PI3K and p-Akt expression (p< 0.05). Conclusion: Xijiao Dihuang Decoction exhibits therapeutic efficacy in treating Sepsis-Induced Acute Lung Injury through its anti-inflammatory, antioxidant, and anti-apoptotic effects, and by modulating the PI3K/Akt pathway. This study provides experimental evidence for Xijiao Dihuang Decoction’s mechanisms, highlighting its potential. However, additional in vivo and clinical investigations are required to validate its efficacy.

30 August 2010 in Journal of Inorganic Materials
Verified
Journal Article
Closed access
XTXiao Tang
Xiao Tang
HSHongli Suo
Hongli Suo
SYShuai Ye
Shuai Ye
MLMin Liu
Min Liu
ZWZi-Ping Wu
Zi-Ping Wu
MZMeiling Zhou
Meiling Zhou

To elevate the productivity of high critical current YBCO superconducting films by TFA-MOD processing, traditional trifluoroacetate (TFA) was replaced by acrylic acetate partially. Since the fluorine content in precursor solution was decreased, the ramping rate in decomposition process reached 300¡䮨. Meanwhile the atmosphere was also adjusted to avoid the fatal effect of diethanolamine (DEA), and to increase thickness of YBCO film. By increasing the maximum of DEA addition to 0.75g/5mL, the thickness of film reaches 1μm. While some a-axis grains dispersed on the film surface are probably ascribed to the rise of thickness, the YBCO film has good interior microstructures overall. As a result, the highest critical current density is 3.5MA/cm2 and the critical temperature is 90K as well.


1 February 2022 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
QZQiliang Zhao
Qiliang Zhao
LZLei Zhang
Lei Zhang
SZShuo Zhang
Shuo Zhang
XGXiaoxue Gao
Xiaoxue Gao
YLYuye Li
Yuye Li
MLMin Liu
Min Liu
Traditional Chinese medicine (TCM) treatment for the coronavirus disease 2019 (COVID-19) can improve clinical symptoms, but it is not clear whether it can shorten viral shedding. This is an observational study including 97 patients with COVID-19 who were consecutively admitted to the Jiangxia Fangcang hospital in Wuhan (Hubei, China) from January 15, 2020, to March 10, 2020. All patients were treated with TCM, and we assessed the patients daily and collected clinical information via a diary card. The primary endpoint was the time to achieve a negative result for severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) RT-PCR. The final analysis included 92 patients. The median time to negative oropharyngeal swab for all the participants was 22 days (IQR 15–30). The participants were divided into three groups according to time from symptom onset to start of TCM treatment: within 7 days group (early treatment group), 8–14 days group (middle treatment group), and over 14 days group (late treatment group). The median time to negative oropharyngeal swab for the early treatment group was 14 days (IQR 12–17) and for the middle and late treatment groups was statistically shorter than 20 days (IQR 18–22) and 30 days (IQR 25–34), respectively. In univariate Cox proportional hazards regression analysis, the incidence of negative oropharyngeal swab for the early and middle treatment groups was 7.674 times and 3.609 times statistically higher than the late treatment group, respectively; whereas in multivariate Cox proportional hazards regression analysis, the incidence for the early and middle treatment groups was 18.093 times and 5.804 times statistically higher than the late treatment group, respectively. In patients with moderate COVID-19, those who had no cough, no dyspnea, and those who received TCM treatment earlier could achieve nucleic acid negative sooner by shortening viral shedding.

18 April 2026 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
YBYu Bao
Yu Bao
HZHailan Zhao
Hailan Zhao
SYShiyuan Yang
Shiyuan Yang
TZTongtong Zhang
Tongtong Zhang
MLMin Liu
Min Liu
XZXue Zhu
Xue Zhu
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung disease characterized by aberrant immune responses and tissue remodeling. L